share_log

CVS Health Announces Pharmacy and Consumer Wellness Leadership Appointments

CVS Health Announces Pharmacy and Consumer Wellness Leadership Appointments

西維斯健康宣佈藥房和消費健康領導職位任命
西维斯健康 ·  12/02 21:00

WOONSOCKET, R.I., December 3, 2024 — CVS Health (NYSE: CVS) today announced that Len Shankman will be president, Pharmacy and Consumer Wellness (PCW), reporting to Prem Shah, group president, CVS Health. In addition, the company announced the appointment of Lucille Accetta, RPh, MPH, MBA as chief pharmacy officer, also reporting to Shah. Both appointments are effective immediately.

伍倫索克,羅德島,2024年12月3日 — 西維斯健康(紐交所:CVS)今天宣佈,倫·香克曼將擔任藥房與消費健康(PCW)總裁,向西維斯健康集團總裁普瑞姆·沙阿彙報。此外,公司還宣佈任命魯西爾·阿切塔爲首席藥房官,亦向沙阿彙報。這兩項任命立即生效。

As president, Pharmacy and Consumer Wellness, Shankman will oversee the front store and retail pharmacy businesses across the company's more than 9,000 CVS Pharmacy locations. In his new role, Shankman will lead the team in continuing to deliver integrated digitally-led experiences that address consumer's health and wellness needs when and where they need us.

作爲藥房和消費健康的總裁,Shankman將監督公司在超過9,000個西維斯藥房地點的前臺和零售藥房業務。在新的角色中,Shankman將帶領團隊繼續提供集成的數字驅動體驗,滿足消費者在需要我們的時候和地方的健康和保健需求。

Shankman joined CVS Health in 2002 and has held positions of increasing responsibility, most recently serving as senior vice president and chief financial officer, Pharmacy and Consumer Wellness. Shankman has also held leadership positions in the company's Specialty Pharmacy business and as general manager for Coram, the CVS Specialty infusion business. Before joining CVS Health, Shankman served in the United States Navy.

Shankman於2002年加入西維斯健康,曾擔任多個逐步增加責任的職位,最近擔任藥房和消費健康的高級副總裁兼首席財務官。Shankman在公司的專科藥房業務和作爲Coram西維斯專科輸液業務的總經理崗位上也曾擔任領導職務。在加入西維斯健康之前,Shankman曾在美國海軍服役。

"Len has a deep knowledge of our Pharmacy and Consumer Wellness business and our company, and his focus on strategy execution, operational strength, and financial performance will help us continue to lead in the market," said CVS Health president and CEO David Joyner. "His disciplined, strategic guidance will further position CVS Pharmacy as a trusted resource for the communities we serve."

「Len對我們的藥房和消費健康業務以及公司有深刻的了解,他對策略執行、運營實力和財務表現的關注將幫助我們繼續在市場上保持領先,」西維斯健康總裁兼首席執行官David Joyner說道。「他嚴謹的戰略指導將進一步使西維斯藥房成爲我們服務社區的可靠資源。」

As chief pharmacy officer, Accetta will advocate for the role of the pharmacist in health care and will be responsible for creating and implementing strategic opportunities to connect our pharmacy assets across the CVS Health enterprise. She will also continue to oversee the Specialty Pharmacy, Coram and Omnicare businesses in her role as senior vice president, Specialty Pharmacy Operations.

作爲首席藥學官,Accetta將爲藥劑師在醫療保健中的角色倡導,並將負責創建和實施戰略機會,以連接我們在西維斯健康企業中的藥房資產。她還將繼續在專科藥房、Coram和Omnicare業務中擔任高級副總裁,專注於專科藥房運營。

Since joining CVS Health in 2017, Accetta has held roles with increasing responsibility within the Specialty Pharmacy business. Prior to joining the company, she held leadership roles at Teva Pharmaceuticals, Rx Ally, Express Scripts and Medco, building her skills in patient services management, pharmacy product development and clinical operations.

自2017年加入西維斯健康以來,Accetta在專科藥房業務中擔任了越來越多責任的職位。在加入公司之前,她曾在Teva製藥、Rx Ally、Express Scripts和Medco擔任領導職務,提升了她在患者服務管理、藥房產品開發和臨床運營方面的技能。

"Our specialty pharmacy is entrusted with the care of people who are facing challenging and complex diagnoses, and Lucille leads with heart, driving the operational excellence our patients deserve along with instilling in our team an unwavering focus on caring for patients," said Joyner. "Her passion and commitment to the practice of pharmacy make her an excellent advocate for the profession."

"我們的專科藥房承擔着面對具有挑戰性和複雜診斷患者的護理,Lucille用心領導,推動我們的患者應得的運營卓越,同時在我們的團隊中灌輸對患者關懷的堅定專注," Joyner說道。"她對藥房實踐的熱情和承諾使她成爲這份職業的優秀倡導者。"

On its most recent earnings call, the company highlighted recent positive trends in the Pharmacy and Consumer Wellness business:

在最新的業績會上,公司強調了藥品和消費健康業務的積極趨勢:

  • Our performance reflects strong execution and the benefit of strategic investments in both our workflows and our colleagues.

  • 我們的業績反映了強有力的執行力和在工作流程和同事方面的戰略投資帶來的好處。

  • We have achieved record high retail pharmacy prescription share of 27.3 percent.

  • 我們在零售藥房處方份額上達到了27.3%的歷史高點。

  • We continue to progress in the transition to the CVS CostVantage model, having reached agreements covering more than half of our total commercial prescriptions.

  • 我們在向CVS CostVantage模型過渡的過程中不斷取得進展,已達成覆蓋一半以上的商業處方協議。

About CVS Health

關於西維斯健康

CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

CVS Health是領先的健康解決方案公司,通過我們的本地存在、數字渠道和超過300,000名專職同事——包括超過40,000名醫生、藥劑師、護士和執業護士——接觸到更多的人,並通過我們的本地存在、數字渠道和超過300,000名專職同事,提高了美國社區的健康狀況。無論何時何地,人們需要我們,在關鍵時刻,我們幫助他們管理慢性疾病,遵守他們的藥物治療,或以最方便的方式接觸到負擔得起的健康和健身服務。我們幫助人們在健康護理系統中導航,並改善他們的個人醫療保健,提供幫助,降低成本,併成爲每一個重要的健康時刻的可靠夥伴。我們每天都充滿熱情地關心所有人。在社交媒體上關注@CVSHealth。

Media contact

媒體聯繫人

Ethan Slavin
860-273-6095
Ethan.Slavin@CVSHealth.com

伊桑·斯拉文
860-273-6095
Ethan.Slavin@CVSHealth.com

Investor contact

投資者聯繫人

Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com

拉里·麥格拉思
800-201-0938
InvestorInfo@CVSHealth.com

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論